Clinical Neuroscience Solutions - Jacksonville

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes1 trial

Phase

• Phase 33 trials
• Phase 11 trial
• Phase 1/21 trial
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Enrolling by invitation1 trial
• Recruiting1 trial

Lead sponsor

• Amgen3 trials
• Transcend Therapeutics2 trials
• Corium, Inc.1 trial

Running trials

• Recruiting

  Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  NCT07684235· Phase 3· Amgen· Source

• Enrolling by invitation

  An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD

  NCT07670702· Phase 3· Transcend Therapeutics· Source

• Active, not recruiting

  Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

  NCT06858839· Phase 3· Amgen· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting

Closed trials

• Completed

  Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

  NCT06585462· Phase 1· Amgen· Source

• Completed

  An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD

  NCT05685732· Phase 4· Corium, Inc.· Source

• Completed

  A Study to Assess the Use of Methylone in the Treatment of PTSD

  NCT05741710· Phase 1/2· Transcend Therapeutics· Source